titoli, abstracts, parole chiave >>>
Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis: case report

Sotgiu, Stefano and Murrughile, Maria R. and Constantin, Gabriela (2010) Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis: case report. BMC Neurology, Vol. 10 , p. 1-8. ISSN 1471-2377. Article.

[img]
Preview
Full text disponibile come PDF Richiede visualizzatore di PDF come GSview, Xpdf o Adobe Acrobat Reader
Available under License Creative Commons Attribution.

791Kb

DOI: 10.1186/1471-2377-10-84

Abstract

Background. Multiple sclerosis (MS) is considered an autoimmune disease of the central nervous system and therapeutic inhibition of leukocyte migration with natalizumab, an anti-alpha4 integrin antibody, is highly effective in patients with MS. Recent studies performed in experimental animal models with relevance to human disease suggested a key role for blood-brain barrier damage and leukocyte trafficking mechanisms also in the pathogenesis of epilepsy. In addition, vascular alterations and increased leukocyte accumulation into the brain were recently documented in patients with refractory epilepsy independently on the disease etiology.

Case report. Here we describe the clinical course of a 24-year-old patient with MS in whom abrupt tonic-clonic generalized seizures manifested at disease onset. Although MS had a more favorable course, treatment with glatiramer acetate and antiepileptic drugs for 7 years had no control on seizure generation and the patient developed severe refractory epilepsy. Interestingly, generalized seizures preceded new MS relapses suggesting that seizure activity may contribute to MS worsening creating a positive feedback loop between the two disease conditions. Notably, treatment with natalizumab for 12 months improved MS condition and led to a dramatic reduction of seizures.

Conclusion. Our case report suggests that inhibition of leukocyte adhesion may represent a new potential therapeutic approach in epilepsy and complement the traditional therapy with anti-epileptic drugs.

Item Type:Article
ID Code:5369
Status:Published
Refereed:Yes
Uncontrolled Keywords:Multiple sclerosis (MS), natalizumab, refractory epilepsy
Subjects:Area 06 - Scienze mediche > MED/26 Neurologia
Divisions:001 Università di Sassari > 01 Dipartimenti > Neuroscienze, scienze materno infantili
Publisher:PubMed Central
ISSN:1471-2377
Copyright Holders:© 2010 Sotgiu et al.; licensee BioMed Central Ltd.
Deposited On:27 Jan 2011 13:52

I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore

Repository Staff Only: item control page